Suppr超能文献

波兰一个家庭中的一例VI型黏多糖贮积症病例。基因检测及基因型-表型关系在黏多糖贮积症诊断中的重要性。

A case of mucopolysaccharidosis type VI in a polish family. Importance of genetic testing and genotype-phenotype relationship in the diagnosis of mucopolysaccharidosis.

作者信息

Zapała Barbara, Chmura Olaf, Ciałowicz Urszula, Solnica Bogdan, Krajewska-Włodarczyk Magdalena, Żuber Zbigniew

机构信息

Department of Clinical Biochemistry, Jagiellonian University Medical College, Cracow, Poland.

Jagiellonian University Medical College, Cracow, Poland.

出版信息

Mol Genet Metab Rep. 2020 Oct 28;25:100658. doi: 10.1016/j.ymgmr.2020.100658. eCollection 2020 Dec.

Abstract

BACKGROUND AND OBJECTIVES

Mucopolysaccharidosis type VI (MPS VI) is a rare, autosomal recessive lysosomal storage disorder caused by deficient enzymatic activity of -acetyl galactosamine-4-sulphatase, which is caused by mutations in the arylsulphatase B () gene. To date, 163 different types of mutations in the have been reported. However, the full mutation spectrum in the MPS VI phenotype is still not known. The aim of this study was to perform molecular testing of the gene in the patient and his family members to confirm MPS VI.

METHODS

Molecular characterisation of the gene was performed using Sanger sequencing. We studied a child suspected of having MPS VI and 16 other relatives.

RESULTS

We identified a C-to-T transition resulting in an exchange of the Arg codon 160 for a premature stop codon (R160*, in exon 2). The transition was in CpG dinucleotides.

INTERPRETATION AND CONCLUSIONS

The study provided some insights into the genotype-phenotype relationship in MPS VI and the importance of genetic testing when diagnosing MPS, which is not a mandatory test for the diagnosis and only very occasionally performed. Additionally, we present here the history of a family with confirmed MPS VI, which is extremely rare especially in south-eastern Poland. What is more, the position where the mutation is located is very interesting because it is the region of CpG, which is the site of the methylation process. Thus, this opens the possibility of a new approach indicating the involvement of an epigenetic mechanism that should be examined in the context of the pathomechanism of MPS.

摘要

背景与目的

黏多糖贮积症 VI 型(MPS VI)是一种罕见的常染色体隐性溶酶体贮积病,由 N - 乙酰半乳糖胺 - 4 - 硫酸酯酶的酶活性缺乏引起,该酶活性缺乏由芳基硫酸酯酶 B(ARSB)基因突变所致。迄今为止,已报道 ARSB 基因有 163 种不同类型的突变。然而,MPS VI 表型的完整突变谱仍不清楚。本研究的目的是对患者及其家庭成员进行 ARSB 基因的分子检测,以确诊 MPS VI。

方法

采用桑格测序法对 ARSB 基因进行分子特征分析。我们研究了一名疑似患有 MPS VI 的儿童及其他 16 名亲属。

结果

我们鉴定出一个 C 到 T 的转换,导致外显子 2 中第 160 位的精氨酸密码子被提前终止密码子(R160*)替换。该转换发生在 CpG 二核苷酸中。

解读与结论

本研究为 MPS VI 的基因型 - 表型关系以及 MPS 诊断时基因检测的重要性提供了一些见解,基因检测并非 MPS 诊断的强制检测项目,仅偶尔进行。此外,我们在此展示了一个确诊为 MPS VI 的家庭的病史,这在波兰东南部极为罕见。更重要的是,突变所在的位置非常有趣,因为它是 CpG 区域,是甲基化过程的位点。因此,这为一种新方法开辟了可能性,该方法表明应在 MPS 的发病机制背景下研究表观遗传机制的参与情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fc0/7600365/564eef77b5cc/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验